标题
Sclerostin Protects Against Vascular Calcification Development in Mice
作者
关键词
-
出版物
JOURNAL OF BONE AND MINERAL RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-01-18
DOI
10.1002/jbmr.4503
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Microvasculopathy and soft tissue calcification in mice are governed by fetuin-A, magnesium and pyrophosphate
- (2020) Anne Babler et al. PLoS One
- Sclerostin as Regulatory Molecule in Vascular Media Calcification and the Bone–Vascular Axis
- (2019) Annelies De Maré et al. Toxins
- The Vicious Cycle of Arterial Stiffness and Arterial Media Calcification
- (2019) Geoffrey Van den Bergh et al. TRENDS IN MOLECULAR MEDICINE
- Sclerostin deficiency modifies the development of CKD-MBD in mice
- (2018) Nadine Kaesler et al. BONE
- Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidates
- (2018) Hanne Skou Jørgensen et al. CLINICAL NEPHROLOGY
- A Prospective Cohort Study Showing No Association Between Serum Sclerostin Level and Mortality in Maintenance Hemodialysis Patients
- (2018) Madoka Sato et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder
- (2018) Ellen Neven et al. KIDNEY INTERNATIONAL
- Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity
- (2018) Keertik Fulzele et al. BONE
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases
- (2016) Christian Freise et al. BMC Cardiovascular Disorders
- Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells
- (2016) Mayumi Ukita et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy
- (2015) Markus Tölle et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?
- (2015) Albina Nowak et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications
- (2015) Chih-Yu Yang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
- (2014) C. Drechsler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients
- (2014) Pierre Delanaye et al. NEPHRON CLINICAL PRACTICE
- Romosozumab in Postmenopausal Women with Osteopenia
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum sclerostin is an independent predictor of mortality in hemodialysis patients
- (2014) Flávia Letícia Carvalho Gonçalves et al. BMC Nephrology
- Warfarin Induces Cardiovascular Damage in Mice
- (2013) Thilo Krüger et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Sclerostin: Another Vascular Calcification Inhibitor?
- (2013) Kathleen J. Claes et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Renal Elimination of Sclerostin Increases With Declining Kidney Function
- (2013) Daniel Cejka et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum Dickkopf 1 Levels in Sclerostin Deficiency
- (2013) A. H. van Lierop et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
- (2013) L. Viaene et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium
- (2013) Z. C. Ryan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel model of adenine-induced tubulointerstitial nephropathy in mice
- (2013) Ting Jia et al. BMC Nephrology
- Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
- (2013) Vincent M Brandenburg et al. BMC Nephrology
- Van Buchem disease: Clinical, biochemical, and densitometric features of patients and disease carriers
- (2012) Antoon H van Lierop et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cell biological and physicochemical aspects of arterial calcification
- (2011) Ellen Neven et al. KIDNEY INTERNATIONAL
- The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
- (2011) Dongxing Zhu et al. PLoS One
- Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice
- (2009) Ina Kramer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The emerging role of phosphate in vascular calcification
- (2009) Cecilia M. Giachelli KIDNEY INTERNATIONAL
- Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started